TrialAnnals of the rheumatic diseases2011

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).

Pierre Quartier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.